Source link : https://www.newshealth.biz/health-news/tezepelumab-for-severe-asthma-improves-the-odds-of-a-good-nights-sleep/
BOSTON — Patients with severe, uncontrolled asthma had significantly higher odds of improvement in asthma-related sleep disturbances and improvement in activity levels when treated with tezepelumab (Tezspire), a post-hoc analysis of the phase III NAVIGATOR trial showed. At 52 weeks, patients on tezepelumab were 40% to 62% more likely than placebo recipients to report improvements […]
Author : News Health
Publish date : 2024-10-11 19:04:57
Copyright for syndicated content belongs to the linked Source.